Oculus, a German manufacturer of ophthalmic instruments and devices, is to incorporate Brien Holden Vision Institute’s (BHVI) algorithms for tracking and estimating refractive error into its Myopia Master ophthalmic instruments. According to Oculus, its Myopia Master is the world’s first device to combine all the important measurement methods of myopia management: axial length, refraction values and the central corneal radii. BHVI’s predictive algorithm is useful for managing myopia in children, where we are seeing the highest progression rates.
Yvette Waddell, BHVI’s CEO said the license agreement is an example of the cutting-edge technologies BHVI is engaged in.
“BHVI literally ‘wrote the book’ on Myopia when its seminal research paper Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050 was published in 2016. Our agreement with Oculus will see our research translated into more instruments that optometrists can use to manage myopia, globally,” she said.
Prof Padmaja Sankaridurg, Head, Myopia Program at BHVI said, “Using large and expansive datasets generated on our own and in collaboration with our research partners across the globe, the team at BHVI is continually engaged in expanding the state of knowledge as well as bringing solutions to reverse the rising myopia epidemic. We are delighted for the opportunity to work together with leading ophthalmic industry such as Oculus to translate some of this knowledge.”
